Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1992 Nov;82(11):1531–1533. doi: 10.2105/ajph.82.11.1531

Implications of the revised surveillance definition: AIDS among New York City drug users.

D C Des Jarlais 1, J Wenston 1, S R Friedman 1, J L Sotheran 1, R Maslansky 1, M Marmor 1, S Yancovitz 1, S Beatrice 1
PMCID: PMC1694601  PMID: 1359800

Abstract

The Centers for Disease Control (CDC) has proposed revising the AIDS surveillance definition to include any HIV-seropositive person with a CD4 cell count of less than 200 cells per microliter. Based on a study of persons receiving treatment for HIV infection, this new definition would lead to an estimated 50% increase in the number of persons recognized as living with AIDS. Among 440 HIV-seropositive research subjects recruited from drug treatment programs and through street outreach in New York City, 59 met this definition, yet only 25% of those had been reported to the New York City AIDS registry. The new definition, if combined with HIV and T-cell testing at drug treatment and street outreach programs, could thus yield very large increases in the number of injecting drug users meeting the new surveillance definition of AIDS.

Full text

PDF
1531

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Des Jarlais D. C., Friedman S. R., Marmor M., Cohen H., Mildvan D., Yancovitz S., Mathur U., el-Sadr W., Spira T. J., Garber J. Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users. AIDS. 1987 Jul;1(2):105–111. [PubMed] [Google Scholar]
  2. Des Jarlais D. C., Friedman S. R., Novick D. M., Sotheran J. L., Thomas P., Yancovitz S. R., Mildvan D., Weber J., Kreek M. J., Maslansky R. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA. 1989 Feb 17;261(7):1008–1012. doi: 10.1001/jama.261.7.1008. [DOI] [PubMed] [Google Scholar]
  3. Farizo K. M., Buehler J. W., Chamberland M. E., Whyte B. M., Froelicher E. S., Hopkins S. G., Reed C. M., Mokotoff E. D., Cohn D. L., Troxler S. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA. 1992 Apr 1;267(13):1798–1805. [PubMed] [Google Scholar]
  4. Margolick J. B., Muñoz A., Vlahov D., Solomon L., Astemborski J., Cohn S., Nelson K. E. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection. JAMA. 1992 Mar 25;267(12):1631–1636. [PubMed] [Google Scholar]
  5. Minkoff H. L., DeHovitz J. A. Care of women infected with the human immunodeficiency virus. JAMA. 1991 Oct 23;266(16):2253–2258. [PubMed] [Google Scholar]
  6. Selwyn P. A., Feingold A. R., Hartel D., Schoenbaum E. E., Alderman M. H., Klein R. S., Friedland G. H. Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS. 1988 Aug;2(4):267–272. doi: 10.1097/00002030-198808000-00005. [DOI] [PubMed] [Google Scholar]
  7. Stoneburner R. L., Des Jarlais D. C., Benezra D., Gorelkin L., Sotheran J. L., Friedman S. R., Schultz S., Marmor M., Mildvan D., Maslansky R. A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City. Science. 1988 Nov 11;242(4880):916–919. doi: 10.1126/science.3187532. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES